Trusted by leading pharmacy organisations and labs
As a pioneer in DNA analysis, we actively collaborate with leading partners in the field.
Enabling treatment success across the healthcare ecosystem
iGene Pharmaco helps pharmacy organisations, laboratories, and pharmacists deliver clear, clinically-relevant medication guidance to healthcare professionals and patients.
Hospitals and labs
Free your staff from the complexity of pharmacogenetic reporting. Our PGx Dose Support System turns your raw lab data into easy-to-read reports in real-time.
Pharmacy organisations
Scale dosing advice across your entire network. Build long-term client loyalty with personalised medication advice for every prescription.
Pharmacists
Be the expert doctors and patients turn to for DNA-guided prescribing in the age of personalised medicine. Expand your services with genetic consultations.
It’s time for a comprehensive pharmacogenetics solution that works across the entire healthcare system
So doctors and pharmacists can personalise prescriptions with pharmacogenetics, and easily share test results with patients.
THE iGENE PHARMACO WAY
-
Get instant, easy-to-understand dosing advice in the same system you use to fill scripts
-
A single test analyzes all key enzymes, providing lifelong benefits
-
Labs and pharmacies collaborate via a shared system to deliver integrated, patient-centred care
-
Hassle-free implementation with a plug-and-play platform, white-labeling, and logistics
“Now, treatment can be tailored instead of trial and error”
Important to know the information
I'm very happy with my "passport" and think it's important to know this information. I'll take it to my pharmacy so they can take it into account when determining my medication dose, whenever I need it in the future.
Good, clear descriptions in understandable language.
Received answers to suspected genetic abnormalities. This is a test that should be included as standard in health insurance, especially at a young age. The medication passport is also very useful. Now, treatment can be tailored instead of trial and error.
The DNA test provider that also provides genotyping, clinical safety alerts, and dosing recommendations
Research shows that adjusting dosage based on DNA reduces drug side effects
Up to 95% of people carry at least one genetic variation that may affect how they process medications².
Genes contribute to up to 30% of the variability in drug response, including for common drugs like blood thinners and antidepressants³.
A large European study found that DNA-guided prescribing reduced serious drug side effects in
1 out of 3 people⁴.
Enhancing collaboration with full interoperability
iGene Pharmaco enables pharmacists, doctors and lab technicians to collaborate
in a shared system to deliver better, more personalised patient care.
✓
Integrates with lab information systems
✓
Integrates with healthcare provider EHRs
✓
Integrates with pharmacy management systems
{{ metaobjects.trustcard["section-title"].titel.value }}
Private by design
Based on the latest guidelines
Certified and compliant
Leading institutions and pharmacists choose iGene for reliable, safe pharmacogenetic testing and reporting
More than a test or reporting tool, iGene Pharmaco is a full-service partner you can always count on
Pharma and genetics expertise
Our team brings decades of experience in pharmaceuticals and applied genetics and knows how to make pharmacogenetics clear and actionable.
Fast, hassle-free implementation
The PGx Dose Support System is fully streamlined and effortless. We’ve done numerous large-scale implementations and will get you up and running in no time.
Zero workflow disruption
iGene Pharmaco integrates with your existing processes, system, and brand to ease your operations and deliver a smooth, professional client experience.
Why stick to standard dosing when you can effortlessly personalise prescriptions?
Footnotes
¹ ² Kabbani, D., et al. “Pharmacogenomics in Practice: A Review and Implementation Guide.” Frontiers in Pharmacology, vol. 14, 17 May 2023, article 1189976, doi:10.3389/fphar.2023.1189976.
³ Farmacogenetica in de apotheek. Antwerps Farmaceutisch Tijdschrift, September 2023, pp. 6–15.
⁴ Swen, Jesse J., et al. “A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.” The Lancet 401.10374 (2023): 347-356.